Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials
Adjunct Collection of Additional Biorepository Data From Patients Enrolled in DFC Trials
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Katy Clark, MA
- Phone Number: 7346156767
- Email: DFC-DCC-PM@umich.edu
Study Contact Backup
- Name: Tina Lucas, BS
- Email: DFC-DCC-PM@umich.edu
Study Locations
-
-
California
-
Palo Alto, California, United States, 94305
- Stanford University
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
-
Florida
-
Miami, Florida, United States, 33126
- University of Miami
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Provides written informed consent
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Age > 18 years
- Previous diagnosis of Type 1 or Type 2 diabetes or pre-diabetes per American Diabetes Association (ADA) guidelines
- Inclusion in a part of any planned or approved DFC protocol
Exclusion Criteria:
- An individual who meets exclusion criteria of the primary DFC protocol in which they are enrolled will also be excluded from participation in the biorepository program as well.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participants consenting
Time Frame: Up to 2 years
|
Proportion of participants consenting to participation in the biorepository from among DFC studies, by study and overall
|
Up to 2 years
|
|
Biospecimens collected
Time Frame: Up to 2 years
|
Proportion of biospecimens collected, by type, from among those expected, by study and overall
|
Up to 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Brian Schmidt, DPM, University of Michigan
- Study Chair: Cathie Spino, ScD, University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HUM00193015
- 5U24DK122927-03 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.